Orchard Therapeutics Announces Comprehensive Presence at 19th Annual WORLDSymposium
BOSTON and LONDON, Feb. 08, 2023 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq:ORTX), a global gene therapy leader, today announced a series of presentations from across its neurometabolic portfolio will be featured at the 19th Annual WORLDSymposium taking place February 22-26, 2023, in Orlando, Florida.
Related news for (ORTX)
- Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
- Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
- Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
- Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
- Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD